Beam Therapeutics Announces Positive Data in Trial Demonstrating First Ever Clinical Genetic Correction of a Disease-causing Mutation
On Mar. 10, 2025, Beam Therapeutics announced initial safety and efficacy data from its Phase 1/2 trial of…
-
-
Biotechnology | Diagnostics | NIH | Oncology | Radiology
Blood test identified acute myeloid leukemia patients at greater risk for relapse after bone marrow transplant
On Mar. 7, 2023, researchers at the National Institutes of Health reported the benefits of screening adult patients…
-
PerkinElmer launched comprehensive solutions for detecting SARS-CoV-2 mutations
On Mar. 9, 2021, PerkinElmer announced the launch of the PerkinElmer COVID-19 Antigen Test for the qualitative detection…
